Your browser doesn't support javascript.
Patterns of self-reported recovery from chemosensory dysfunction following SARS-CoV-2 infection: insights after 1 year of the pandemic.
Almutairi, Dakheelallah M; Almalki, Abdulaziz H; Mirza, Ahmad A; Khalifah, Mohammed J; Aljefri, Ammar A; Alsalmi, Khalid A; Al-Thaqafy, Majid S; Algarni, Mohammed A.
  • Almutairi DM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  • Almalki AH; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
  • Mirza AA; Department of Otolaryngology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Khalifah MJ; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  • Aljefri AA; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
  • Alsalmi KA; Department of Otolaryngology - Head and Neck Surgery, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Al-Thaqafy MS; Department of Otolaryngology - Head and Neck Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Algarni MA; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Acta Otolaryngol ; 142(3-4): 333-339, 2022.
Article in English | MEDLINE | ID: covidwho-1805774
ABSTRACT

BACKGROUND:

The coronavirus disease (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes chemosensory dysfunction. AIMS/

OBJECTIVES:

To determine the characteristics of chemosensory dysfunction and to identify factors associated with chemosensory complete recovery and time to recovery. MATERIALS AND

METHODS:

This cross-sectional study included all patients presenting with chemosensory dysfunction and confirmed SARS-CoV-2 infection from May to August 2020 who underwent telemedicine follow-up after 1 year to assess their chemosensory recovery.

RESULTS:

A total of 372 patients were included, of which 53.8% were male. The mean age ± SD was 37.45 ± 13.44. The majority experienced combined (olfactory and gustatory) dysfunction (85.7%), and 315 patients (84.7%) had complete loss of chemosensory function. The independent predictors associated with a low likelihood of complete recovery were parosmia (aOR 0.16, p < .001), upper respiratory tract symptoms (aOR 0.28, p = .001), and dyspnoea (aOR 0.21, p < .001), whereas the factors associated with a long recovery period were parosmia (aOR 12.04, p = .002), headache (aOR 7.19, p = .007), and hypertension (aOR 7.76, p = .039).

CONCLUSIONS:

A full recovery outcome was predominant. The presence of parosmia was linked to both an incomplete recovery and a long time to recovery.

SIGNIFICANCE:

Parosmia and respiratory symptoms are implicated in the incomplete recuperation of chemosensory function.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Olfaction Disorders Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Female / Humans / Male Language: English Journal: Acta Otolaryngol Year: 2022 Document Type: Article Affiliation country: 00016489.2022.2062047

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Olfaction Disorders Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Female / Humans / Male Language: English Journal: Acta Otolaryngol Year: 2022 Document Type: Article Affiliation country: 00016489.2022.2062047